Shortening the lipohilic tail

To overcome the solubility problem of the oligonucleotide-catalipids conjugate 13 a new generation of catalipids was synthesized based on the substructure of MOH (8) (Fig. 18). Catalipids -as well as oligonucleotide-catalipid conjugates- with shorter alkyl chains are supposed to have a better solubility in the required ligation buffer.



Figure 18  Synthesis of catalipids MC6H (18), MC8H (19) and MC10H (20).


In order to use NMR spectroscopy to study chemical characteristics millimolar concentrations are required. Thus the synthesis of MC6H (18), MC8H (19) and MC10H (20) was carried out in solution to arrive at a sufficient amount of products. Catalipids 18 to 20 are accessible by coupling hexanoic-, octanoic- and decanoic carboxylic acids to histamine (Figure 18). After purification using column chromatography, 18 to 20 were analyzed via NMR- and MALDI-MS spectroscopy. The reaction conditions elaborated to synthesize the oligonucleotide-catalipid conjugate 13 were optimized for the new catalipids MC6H (18), MC8H (19), MC10H (20): In a typical experiment 1 µmol of catalipid dissolved in chloroform was transferred into an Eppendorf tube and the solvent was removed by evaporation. To the catalipid coated Eppendorf tube 25 µl buffer (0.1 M HEPES, pH 7.2, 20 % acetonitrile) was added. According to the length of the alkyl chains different solubilities of catalipids in buffered solution were found: MC6H (18) was soluble after sonification for 15 minutes at RT. In the case of MC8H (19) and MC10H (20)) an addition of 5 to 10 % DMF and incubation at 45 °C for one hour was necessary to dissolve these catalipids with longer alkyl chains. To the dissolved catalipid 70 nmol Cy5-labeled pentamer 3'-phosphate (Cy5-TTCCGp 14) in buffer (0.1 M HEPES, pH 7.2, 20% acetonitrile) containing 0.1 M EDC was added and incubated for 2 hours at 30 °C. Purification and desalting of oligonucleotide-catalipids conjugates was performed as described previously for 13. Activated oligonucleotide-catalipid conjugates using catalipids 18, 19 and 20 could be obtained in good yields. The RP-HPLC chromatogram (Fig. 19) and the MALDI-MS spectra (Figure 20) of the MC8H- conjugate (21) are exemplarily shown.


Figure 19  RP-HPLC chromatogram of activated oligonucleotide-catalipid conjugate (21) after purification and desalting.


Figure 20  MALDI-MS spectra of activated oligonucleotide-catalipid conjugate (21), Mcalcd : 2286.9.